High-level quinolone resistance in Enterococcus faecium was associated with mutations in both gyrA and parC genes in 10 of 11 resistant strains. One low-level resistant strain without such mutations may instead possess an efflux mechanism or alterations in the other subunits of the gyrase or topoisomerase IV genes. These findings are similar to those for other gram-positive bacteria, such as Enterococcus faecalis.
Genomic DNA was extracted from the 11 isolates and the type strain, by using the guanidium thiocyanate method (24) . The target regions were amplified by using PCR with primers derived from E. faecalis sequences. A DNA fragment of 241 bp from the gyrA gene corresponding to the quinolone resistance determining region was amplified with the 23-mer oligonucleotide primers 5Ј-CGG GAT GAA CGA ATT GGG TGT GA-3Ј and 5Ј-AAT TTT ACT CAT ACG TGC TTC GG-3Ј, equivalent to nucleotide positions 150 to 172 and 368 to 390 of the E. coli gyrA gene (15) , respectively, and a 191-bp parC fragment was amplified with the 20-mer oligonucleotide primers 5Ј-AAT GAA TAA AGA TGG CAA TA-3Ј and 5Ј-CGC  CAT CCA TAC TTC CGT TG-3Ј (positions 10 to 29 and 181 to 200 of the E. faecalis parC gene, respectively) (14) . One-step PCR was performed for each gene in a 50-l reaction mixture containing 1.25 U of Taq DNA polymerase, 200 M concentrations of each deoxynucleoside triphosphate, 45 pmol of each primer, 1.5 mM MgCl 2 , and 10ϫ PCR buffer (Sigma). Each reaction was run for 30 cycles with the following temperature profile: denaturation at 94°C for 1 min, annealing at 55°C for gyrA and 48.7°C for parC for 1 min, and then extension at 72°C for 1 min. The amplified fragments were processed for cycle sequencing by using the ABI PRISM Big-dye terminator kit, and sequences were then analyzed by capillary electrophoresis in an ABI PRISM 310 automated sequencer. Analysis for alteration in target position was carried out as described by Jalal and Wretlind (11) .
The nucleotide sequences of 195 bp of gyrA between the primers and 151 bp of parC between the primers were then determined and analyzed for alterations at the key amino acid positions. The E. faecium GyrA partial amino acid sequence showed 97, 88, and 63% identities with E. faecalis, Streptococcus pneumoniae, and E. coli, respectively. The corresponding identities for ParC were 92, 78, and 47% (Fig. 1) .
In 10 of the strains GyrA showed single amino acid changes relative to strain ATCC 19434. The serine at position 83 (corresponding to E. coli) was changed to tyrosine in three strains, to isoleucine in one strain, and to arginine in another. At position 87, glutamate was changed to lysine in five isolates. In the parC gene, a single amino acid change was encoded, the serine at position 80 (corresponding to E. coli) to isoleucine in 10 strains (Table 1) . One susceptible strain and one strain for which the MIC of ciprofloxacin was 8 g/ml and that of trovafloxacin was 4 g/ml had no alterations in gyrA or parC.
Two nucleotide substitutions were needed for the alteration of serine (AGT) to tyrosine (TAT). One possible explanation is that the parent strains had serine (TCT) in this position. Kanematsu et al. (14) found similar mutations with two nucleotide changes in E. faecalis at position 80 of the parC gene, where serine (AGT) was changed to arginine (CGC) in one strain and to isoleucine (ATC) in nine strains. Some of the strains in this study showed the same mutations in both gyrA and parC despite the fourfold difference in MICs of ciprofloxacin or trovafloxacin ( Table 1) . The most resistant strains may also have efflux systems and/or mutations in gyrB or parE.
Kanematsu et al. (14) found similar mutations in the gyrA and parC genes of E. faecalis, associated with resistance to fluoroquinolones. They detected one strain with a substitution in parC but not in gyrA. For this strain the MIC was between the MICs for those with no mutations and those with simultaneous mutations in both gyrA and parC; consequently they suggested that parC might be the primary target for quinolones as in other gram-positive bacteria such as S. pneumoniae and S. aureus (16, 17) . In a previous study, Pan and Fisher (20) showed that the quinolone primary target can differ depending on the structure of the compound. They demonstrated that parC is the primary target for ciprofloxacin, whereas gyrA is the primary target for sparfloxacin in laboratory selected mutant strains of S. pneumoniae. However, in the present study we could not determine the quinolone primary target, since we found no isolates with mutations in only one of the genes. For E. faecalis and S. pneumoniae strains with substitutions only in either parC or gyrA, the MICs of at least one of the quinolones studied were eightfold higher or more (14, 20) . For the lowlevel resistant strain in our study the MICs of quinolones were two-to fourfold higher than that for the type strain, and the strain may carry mutations in the other subunits of gyrase and topoisomerase IV or efflux system.
Nucleotide sequence accession numbers. The gyrA and parC partial sequences of E. faecium appear in GenBank under accession no. AF060881 and AB017811, respectively.
